Nicholson Garry A
Insider CIK 1640861 · FPRX Director · TSRO Director · GTHX Director · TPTX Director · NXTC Director · TCRX Director · DAWN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TCRX TScan Therapeutics, Inc. | A Award deriv | 2026-05-20 | 2026-05-22 | 67,000 | — | $0 | 67,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 33,900 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 37,500 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 32,335 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 22,500 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 15,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 33,900 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 32,335 | — | $0 | 32,335 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 32,335 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 37,500 | — | $0 | 37,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2025-11-06 | 2025-11-07 | 37,500 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-11-06 | 2025-11-07 | 33,900 | — | $0 | 33,900 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | A Award deriv | 2025-06-30 | 2025-07-02 | 67,000 | — | $0 | 67,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-06-02 | 2025-06-04 | 22,500 | — | $0 | 22,500 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-06-02 | 2025-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer | 2024-09-18 | 2024-09-18 | 20,000 | — | $0 | 14,389 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | U Tender | 2024-09-18 | 2024-09-18 | 14,389 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2024-06-13 | 2024-06-14 | 10,000 | — | $0 | 34,389 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 47,500 | — | $0 | 47,500 | SEC↗ |
| TCRX TScan Therapeutics, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 23,750 | — | $0 | 23,750 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2024-05-23 | 2024-05-28 | 32,335 | — | $0 | 32,335 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 14,250 | — | $0 | 14,250 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2023-06-22 | 2023-06-26 | 37,500 | — | $0 | 37,500 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2023-06-15 | 2023-06-16 | 10,000 | — | $0 | 24,389 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2022-09-12 | 2022-09-14 | 33,900 | — | $0 | 33,900 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 23,400 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 8,500 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2022-06-23 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2022-06-23 | 2022-06-24 | 14,250 | — | $0 | 14,250 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2022-06-23 | 2022-06-24 | 10,000 | — | $0 | 14,389 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2021-06-24 | 2021-06-28 | 14,250 | — | $0 | 14,250 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 19,620 | — | $0 | 19,620 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2021-06-17 | 2021-06-21 | 4,389 | — | $0 | 4,389 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2021-06-02 | 2021-06-04 | 8,500 | — | $0 | 8,500 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 15,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 10,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 15,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 20,000 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2020-06-15 | 2020-06-17 | 23,400 | — | $0 | 23,400 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2020-06-15 | 2020-06-17 | 25,000 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2020-06-11 | 2020-06-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 28,500 | — | $0 | 28,500 | SEC↗ |
| NXTC NextCure, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 16,083 | — | $0 | 16,083 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2020-05-14 | 2020-05-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2020-01-22 | 2020-01-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2019-06-10 | 2019-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 7,209 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 12,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 12,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 25,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 4,052 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | U Tender | 2019-01-22 | 2019-01-22 | 1,671 | $75.00 | $125.3K | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2018-09-12 | 2018-09-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2018-06-01 | 2018-06-05 | 4,052 | — | $0 | 4,052 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2018-06-01 | 2018-06-05 | 7,209 | — | $0 | 7,209 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2018-05-10 | 2018-05-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2017-06-01 | 2017-06-05 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2017-06-01 | 2017-06-05 | 402 | — | $0 | 1,671 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2017-05-10 | 2017-05-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2016-06-01 | 2016-06-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award | 2016-06-01 | 2016-06-03 | 1,269 | — | $0 | 1,269 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2015-06-01 | 2015-06-03 | 25,000 | — | $0 | 25,000 | SEC↗ |